Evicenter
MarkdownMedical informationP&T meetings
Cretostimogene grenadenorepvec (CG0070)

BCG-unresponsive high-risk non-muscle-invasive bladder cancer

Manufacturer
CG Oncology
Launch
Not announced
Last updated
161 sources

Product information and disease descriptionProduct descriptionProduct information

Generic, brand name and therapeutic class of product

4 evidence topics · 5 sources

Development code and registry intervention names
Registry fieldQuoted record
Intervention name“Cretostimogene Grenadenorepvec”
Other name“CG0070”
Intervention description“Engineered Oncolytic Adenovirus”
Co-administered agent“n-dodecyl-B-D-maltoside”
Co-administered agent description“Transduction-enhancing agent”
Brand name

No evidence found.